Merck, Accenture & Amazon AWS join forces to develop cloud platform

Date: 2018-09-25   Author: Pankaj Singh  Category: #news

Merck, Accenture & Amazon AWS join forces to develop cloud platform

Accenture PLC, a global management consulting and professional services firm, pharma giant Merck, and Amazon Web Services have reportedly joined forces to create a cloud-based informatics research platform.

As per authentic sources, built on Amazon Web Services, this cloud-based platform is one of the services that the Accenture Applied Life Sciences Solutions practice provides. Remarkably, Merck would be the world’s first pharmaceutical company to use it.

According to sources familiar with the development, the new platform would enable scientific research-based organizations perusing work in the life sciences sector to quickly navigate, aggregate, and appraise research data from numerous applications.

Reportedly, under this platform data can be accessed through a single interface, with integrated workflow, report generation, and analytics proficiencies. This apparently facilitates an easy collaboration throughout the R&D organization, together with external associates, through the integration of a modern user interface and a safe, multiple tenant environment, cite credible sources.

Industry experts claim that this platform is ideal for businesses operating in the life sciences industry like biotechnology, scientific research, and pharmaceutical organizations. The platform would seemingly help to enhance efficiency, productivity, and innovation in the initial phases of drug development.

If reports are to be believed, Accenture would create an alliance of clients to monitor and expand the potential of the new platform, introducing an opportunity for pre-competitive association.

Brad Michel, Accenture Scientific Informatics Services’ Managing Director, was quoted stating that acknowledging the industry's requirement to drive faster, more efficient, and groundbreaking scientific research, the organization is rather pleased to team up with Amazon Web Services and Merck to launch the new platform and accompanying ecosystem to assist our clients in accelerating the discovery of novel, targeted treatment options for patients.

For the uninitiated, within a year, Accenture’s shares have grown 25.6 percent, beating the S&P 500's 15.8 percent rally.



About Author


Pankaj Singh linkdin-boxtwitter

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

Post Recommendents

Juul plans to extend stay on FDA ban citing unevaluated evidence

Author: Saipriya Iyer

American electronic cigarette company Juul Labs Inc is reportedly trying to extend an interim stay on the Food and Drug Administration (FDA)’s ban on e-cigarettes.

In a cour...


Shingles Treatments market to register a healthy y-o-y growth rate through 2028

Author: Sachin Pashte

Market Study Report adds new research on Shingles Treatments market, which is a detailed analysis of this business space inclusive of the trends, competitive landscape, and the market size. Encompassing one or more parameters among product analysi...


Comprehensive report of Shock Absorbers Market Projected to Gain Significant Value by 2028

Author: Sachin Pashte

Shock Absorbers market report delivers vital data concerning the drivers, limitations & challenges, product spectrum, application scope, competitive dynamics, and impact of COVID-19 on CAGR.

Request a sample Report of Shock A...